• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

MP Healthcare Venture Management

edit

MPH is a venture capital firm that invest in innovative research and development that focuses in biotechnology, biopharmaceuticals, therapeutics and diagnostics.

Recent Milestones

edit

• 
  MP Healthcare Venture Management invested in Thrasos. (10/25/12)
  Posted 10/25/12 at 7:50pm via businesswire.com
• 
  MP Healthcare Venture Management invested in Genocea Biosciences. (10/10/12)
  Posted 10/10/12 at 7:37pm via masshightech.com
• 
  MP Healthcare Venture Management invested in GenKyoTex. (7/9/12)
  Posted 7/9/12 at 5:36am via yahoo.com
• 
  MP Healthcare Venture Management invested in GenKyoTex. (5/24/11)
  Posted 5/24/11 at 6:10pm via reuters.com
• 
  MP Healthcare Venture Management invested in f-star Biotech. (4/13/11)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  MP Healthcare Venture Management invested in Genocea Biosciences. (1/3/11)
  Posted 1/3/11 at 6:08pm via finsmes.com
• 
  MP Healthcare Venture Management invested in Covagen. (11/29/10)
  Posted 11/29/10 at 7:26pm via covagen.com
• 
  MP Healthcare Venture Management invested in FerroKin Biosciences. (6/18/10)
  Posted 6/20/10 at 3:37am via fiercebiotech.com
• 
  MP Healthcare Venture Management invested in f-star Biotech. (1/6/10)
  Posted 1/6/10 at 8:23pm via f-star.com
• 
  MP Healthcare Venture Management invested in Pronota. (10/30/09)
  Posted 11/29/09 at 5:11pm via pronota.com
• 
  MP Healthcare Venture Management invested in Covagen. (10/5/09)
  Posted 12/1/09 at 11:59am via covagen.com
• 
  MP Healthcare Venture Management invested in Intradigm Corporation. (1/7/09)
  Posted 6/25/09 at 4:40am via fiercebiotech.com

Investments

Videos

Sources

1. Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury (businesswire.com) [edit]
2. Genocea raises $30M to advance herpes vaccine (masshightech.com) [edit]
3. Genkyotex Raises CHF25 Million in Series C Round Extension (finance.yahoo.com) [edit]
4. GenKyoTex raises CHF 18 million in a Series C Venture Financing to develop NOX enzyme inhibitors (reuters.com) [edit]
5. f-star raises €15M in a New Financing led by SR One (f-star.com) [edit]
6. Genocea Biosciences Closes $35M Series B Financing Round (finsmes.com) [edit]
7. Covagen closes Series A financing round with Seroba Kernel as lead investor (covagen.com) [edit]
8. FerroKin rounds up $12M for iron overload treatment Read more: FerroKin rounds up $12M for iron overload treatment - FierceBiotech http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss#ixz (fiercebiotech.com) [edit]
9. f-star raises €8m in an Extended Series A Financing co-led by MP Health-care Venture Management and Merck Serono Ventures (f-star.com) [edit]
10. Pronota (pronota.com) [edit]
11. Covagen (covagen.com) [edit]
12. Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive (fiercebiotech.com) [edit]